Internalization of HMGB1 (High Mobility Group Box 1) Promotes Angiogenesis in Endothelial Cells
Objective:
In patients with peripheral artery disease, blockages in arterioles <1 mm cannot be treated surgically, and there are currently few effective medicines. Studies have shown that inflammation in ischemic tissue is related to injury recovery and angiogenesis, but insufficient attention has been paid to this area. Studies have suggested that HMGB1 (high mobility group protein 1), which is released by ischemic tissue, promotes angiogenesis, but the mechanism is not entirely clear. In this study, we tested the internalization of HMGB1 in endothelial cells and investigated a novel proangiogenic pathway.
Approach and Results:
Using green fluorescent protein–tagged HMGB1 to stimulate endothelial cells, we demonstrated HMGB1 internalization via dynamin and RAGE (receptor for advanced glycation end products)-dependent signaling. Using a fluorescence assay, we detected internalized protein fusion to lysosomes, followed by activation of CatB (cathepsin B) and CatL (cathepsin L). The latter promoted the release of VEGF (vascular endothelial growth factor)-A and endoglin and upregulated the capacities of cell migration, proliferation, and tube formation in endothelial cells. We identified that the cytokine-induced fragment—a key functional domain in HMGB1—mediates the internalization and angiogenic function of HMGB1. We further confirmed that HMGB1 internalization also occurs in vivo in endothelial cells and promotes angiogenesis in mouse femoral artery ligation.
Conclusions:
In this study, we identified a novel pathway of HMGB1 internalization–induced angiogenesis in endothelial cells. This finding sheds light on the regulatory role of inflammatory factors in angiogenesis through cell internalization and opens a new door to understand the relationship between inflammation and angiogenesis in ischemic diseases.
Top-30
Journals
|
1
2
3
|
|
|
Frontiers in Immunology
3 publications, 8.57%
|
|
|
Cells
2 publications, 5.71%
|
|
|
PLoS ONE
2 publications, 5.71%
|
|
|
Bioscience Reports
1 publication, 2.86%
|
|
|
Cell Death and Differentiation
1 publication, 2.86%
|
|
|
Inflammation
1 publication, 2.86%
|
|
|
Biochemical and Biophysical Research Communications
1 publication, 2.86%
|
|
|
Redox Biology
1 publication, 2.86%
|
|
|
European Heart Journal
1 publication, 2.86%
|
|
|
Immunology
1 publication, 2.86%
|
|
|
Disease Markers
1 publication, 2.86%
|
|
|
Oxidative Medicine and Cellular Longevity
1 publication, 2.86%
|
|
|
Cytotherapy
1 publication, 2.86%
|
|
|
Progress in Molecular Biology and Translational Science
1 publication, 2.86%
|
|
|
FEBS Open Bio
1 publication, 2.86%
|
|
|
Biomedicine and Pharmacotherapy
1 publication, 2.86%
|
|
|
International Journal of Biological Macromolecules
1 publication, 2.86%
|
|
|
Biology Bulletin
1 publication, 2.86%
|
|
|
Current Issues in Molecular Biology
1 publication, 2.86%
|
|
|
Cancer Letters
1 publication, 2.86%
|
|
|
Advanced Functional Materials
1 publication, 2.86%
|
|
|
iScience
1 publication, 2.86%
|
|
|
Ageing Research Reviews
1 publication, 2.86%
|
|
|
Journal of Physiology
1 publication, 2.86%
|
|
|
Journal of Inflammation Research
1 publication, 2.86%
|
|
|
Inflammation Research
1 publication, 2.86%
|
|
|
European Journal of Medical Research
1 publication, 2.86%
|
|
|
Frontiers in Cell and Developmental Biology
1 publication, 2.86%
|
|
|
Journal of Advanced Research
1 publication, 2.86%
|
|
|
European Journal of Vascular and Endovascular Surgery
1 publication, 2.86%
|
|
|
1
2
3
|
Publishers
|
2
4
6
8
10
12
|
|
|
Elsevier
11 publications, 31.43%
|
|
|
Springer Nature
6 publications, 17.14%
|
|
|
Frontiers Media S.A.
4 publications, 11.43%
|
|
|
Wiley
4 publications, 11.43%
|
|
|
MDPI
3 publications, 8.57%
|
|
|
Hindawi Limited
2 publications, 5.71%
|
|
|
Public Library of Science (PLoS)
2 publications, 5.71%
|
|
|
Oxford University Press
1 publication, 2.86%
|
|
|
Pleiades Publishing
1 publication, 2.86%
|
|
|
Taylor & Francis
1 publication, 2.86%
|
|
|
2
4
6
8
10
12
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.